• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number RLT281416
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 05/26/2021
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2019, the patient was implanted with a gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.The patient tolerated the procedure.It was reported that images (date and modality is unknown), revealed a proximal type i endoleak.There was aneurysm sac enlargement (amount is unknown).On (b)(6) 2021 there was a reintervention.The physician implanted a gore® excluder® aaa endoprosthesis aortic extender and a palmaz stent.The endoleak was resolved.The patient tolerated the reintervention procedure.
 
Additional Manufacturer Narrative
Addition the gore® excluder® aaa endoprosthesis instructions for use (ifu) states that adverse events that may occur and/or require intervention include but are not limited to endoleak.
 
Additional Manufacturer Narrative
Revised b1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDER AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11935354
Report Number3007284313-2021-01446
Device Sequence Number4345217
Product Code MIH
UDI-Device Identifier00733132622542
UDI-Public00733132622542
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/13/2022
Device Model NumberRLT281416
Device Catalogue NumberRLT281416
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 05/26/2021
Supplement Date Received by Manufacturer05/26/2021
10/19/2021
Initial Report FDA Received Date06/03/2021
Supplement Report FDA Received Date08/10/2021
10/26/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age78 YR
-
-